Open AccessWeekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
Author(s) -
Joseph A. Sparano,
Molin Wang,
Silvana Martino,
Vicky Jones,
Edith A. Perez,
Tom Saphner,
Antonio C. Wolff,
George W. Sledge,
William C. Wood,
Nancy E. Davidson
Publication year - 2008
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0707056
Subject(s) - paclitaxel , docetaxel , adjuvant , medicine , oncology , breast cancer , cancer , adjuvant chemotherapy
We compared the efficacy of two different taxanes, docetaxel and paclitaxel, given either weekly or every 3 weeks, in the adjuvant treatment of breast cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom